With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’

Normunity, a Boston-based biotechnology startup co-founded by cancer immunotherapy pioneer Lieping Chen, emerged from stealth on Tuesday with $65 million in funding and a close alliance with the immunologist’s lab at Yale University’s School of Medicine.